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Renal dysfunction as a possible cause of essential hypertension in
predisposed subjects. In 65 young normotensive subjects with two
hypertensive parents (HP), and in 55 matched subjects with two
normotensive parents (NP), the following factors were measured: renal
plasma flow (RPF), glomerular filtration rate (GFR) both as mutest®
and creatinine clearances; 24-hr urinary output; plasma renin activity(PRA); Na and K in plasma and in 24-hr urine and 24-hr urinary
excretion of aldosterone. In 30 HP and in 34 NP, the cardiac output and
plasma concentrations of noradrenaline, adrenaline, and dopamine
were also measured in the supine position and after 10 mm of standing.
The HP have greater RPF (P < 0.01), faster GFR (P < 0.02), greater 24-
hr urinary output (P < 0.05), and lower PRA (P < 0.01) than the NP. All
the other factors were similar in the two groups of patients. It is
proposed that the differences in renal function in the HP and the NP
may be due to an abnormality in tubular handling of ions and water in
the HP, which may be responsible for the increase in blood pressure in a
proportion of patients with essential hypertension.
Bysfonction rénale une cause possible d'hypertension essentielle chez
des sujets prédisposés. Chez soixante-cinq sujets normotendus jeunes,
avec deux parents hypertendus (HP) et chez 55 sujets appariés avec
deux parents normotendus (NP) les facteurs suivants ont été mesurés:
le debit plasmatique renal (RPF), le debit de filtration glomerulaire
(GFR), par Ia clearance de mutest® et celle de Ia créatinine; le debit
urinaire de 24 hr; l'activité rénine plasmatique (PRA); le Na et le K dans
le plasma et les urines de 24 hr, et l'excrétionjournaliere d'aldostdrone.
Chez 30 HP et chez 34 NP, le debit cardiaque et les concentrations
plasmatiques de noradrénaline, adrenaline, et dopamine ant egalement
été mesurées en position couchde et après 10 mm de station debout. Les
HP ont un RPF plus grand (P < 0,01), un GFR plus élevée (P < 0,02),
un debit urinaire des 24 hr plus élevé (P < 0,05), et une PRA plus faible
(P < 0,0!) que les NP. Tous les autres facteurs étaient identiques dans
les deux groupes de malades. 11 est propose que les differences de
fonction rCnale entre les HP et les NP pourraient être dues a une
anomalie de Ia conservation tubulaire des ions et de l'eau chez les HP,
laquelle pourrait Ctre responsabte de l'augmentation de Ia pression
artérielle chez une certaine proportion de malades atteints d'hyperten-
sion essentielle.
Many studies have shown that there is a genetic contribution
to the development of "essential" hypertension, but the nature
of this contribution is unknown [1]. There must be genetic
factors acting from birth, since there is also a familial aggrega-
tion of blood pressure (BP) in the early years [2, 3]. Therefore,
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studying young normotensive offspring of hypertensive (HP)
and normotensive parents (NP) may provide an opportunity to
detect these factors in a relatively purer state before the
intervention of other secondary mechanisms. The results ob-
tained with genetically hypertensive rats [4, 5], or after renal
artery constriction in conscious dogs [6], clearly demonstrate
that the most characteristic changes linked to the primary cause
of hypertension are detectable only before or during the devel-
opment of hypertension. This has led many investigators to
study this "prehypertensive" phase, and, as a result, different
types of abnormalities, in cell membrane transport mechanisms
[7—9], BP [10], and organ function regulation [11—15] have been
described. We have studied the function of the kidney, the
circulation, and the sympathetic nervous system in these young
subjects. The results of that study are described in this paper
and clearly show that the kidney function of HP is different
from that of NP.
Methods
Subjects. The selection of HP and NP and the measurements
of the different variables were carried out according to the
procedure already described [121. In brief the BP of the
population of small towns near Milan was measured, and the
family trees were constructed. We defined those families in
which the blood pressure of both parents was greater than
150/95 mm Hg on three different occasions, or when one or both
parents received antihypertensive therapy as hypertensive, and
those in which the BP was less than 140/90mm Hg as normoten-
sive. Normotensive offspring aged 14 to 30 years were candi-
dates for this study. For technical reasons kidney function
studies were carried out on one occasion while the hemodynam-
ic and catecholamine studies were carried out on another
occasion. These studies were performed on an out-patient
basis.
Kidney function studies. Twenty-four hour urine samples
were collected from 65 HP and 55 NP for measurement of Na,
K, endogenous creatinine, and aldosterone during the day
before the study. At approximately 8 A.M. the fasting subjects
arrived at the out-patient clinic and, after they were in a supine
position for 30 mm, a blood sample was taken from the subjects'
arms for the measurement of plasma concentrations of Na, K,
creatinine, protein, and plasma renin activity (PRA). Then an
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Subject
GFR
mi/mm 1.73 m2
RPF
mI/mm 1.73 m2
1s 2°' 3rd 1st 2od 3rd
1 117 110 117 744 616 744
2 151 159 141 910 731 785
3 111 117 122 644 633 712
4 130 116 125 657 599 630
5 94 107 122 756 808 790
6 86 96 127 520 534 501
intravenous infusion of PAH and polyfructosan S (mutest®,
Laevosan—Gesellschaft Linz/Danau, Austria) was started. After
an equilibration period of 1 hr and 45 mm, four blood samples
were collected from the opposite arm at 15-mm intervals for the
determination of PAH and mutest®. Measurements of mutest®
and PAH in seven independent samples of the same plasma
yielded a coefficient of variation of 3.3 and 5.1%, respectively.
BP and heart rate (HR) were measured at 30-mm intervals. To
avoid bladder catheterization in healthy individuals, the rate of
PAH and mutest® infusion after 1 hr and 45 mm of equilibration
was assumed to be equal to the rate of excretion through the
urine when a constant plasma concentration had been reached
[161. The plasma levels of the two markers were considered
constant after the equilibration time, when a straight and
horizontal line could be drawn across three values of plasma
concentration and the difference between the largest or the
smallest value did not exceed 5% of the average value given by
the line. Twelve subjects, 7 HP and 5 NP, did not fulfill this
criteria, thus they were not included in the respective groups.
No correction was made for PAH renal extraction since it
has already been shown that this factor is the same in essential
hypertensive patients without renal failure and normal sub-
jects [17]. Plasma and urine Na and K were measured by
flame photometry, PRA and urinary aldosterone by
radioimmunoassay.
Hemodynamic and catecholamine studies. These studies
were carried out in 30 HP and 34 NP. After 1 hr of rest in a
supine position in a quiet and dark room, BP and HR were
measured twice; then cardiac output was measured by echocar-
diography, and BP and HR were recorded again. Immediately
after echography, when the subjects were still lying down,
blood samples were taken for catecholamine and PRA levels.
After 10 mm of standing, other blood samples were taken for
catecholamine and PRA determinations. The blood was re-
moved through an indwelling catheter introduced into an ante-
cubital vein soon after the subjects assumed the supine posi-
tion. Cardiac output was determined by multiplying the differ-
ence between one systolic and one telediastolic diameter of the
heart (obtained by echocardiography) by an arbitrary coeffi-
cient to get the stroke volume, which was then multiplied by the
HR [181. Plasma adrenaline, noradrenaline, and dopamine were
determined radioenzymatically [19]. The difference between the
values for the two groups were analyzed statistically by Stu-
dent's t test for unpaired data, except for the RPF and RBF.
These last were analyzed by Cochran's test because of the
heterogeneity of the variance.
Results
To assess the variability of the clearance techniques, clear-
ances studies were repeated in six normal volunteers (including
three of us) once a week for 3 weeks; the results are shown in
Table 1. The variance analysis yielded a significant difference
between subjects for RPF (P < 0.01) while no significant
difference was found both within and between subjects for GFR
(P > 0.1) and within subjects for RPF (P > 0.1). The estimation
of the coefficient of variation yielded the following results: GFR
between subjects, 12.8%; GFR within subjects, 9.9%; RPF
between subjects, 14.9%; RPF within subjects, 7.9%.
The clinical characteristics of the subjects are shown in Table
2. The table also shows other parameters that are similar in the
two groups. Despite the fact that we have deliberately excluded
12 subjects with BP greater than 160/90 from the group of
offspring of hypertensive families, the average BP of this group
was still slightly higher.
Table 3 shows the values for certain kidney variables record-
ed: RPF, RBF, GFR, and 24-hr urinary output are greater, and
PRA is lower in HP. The difference between the two groups in
GFR creatinine, although of the same order of magnitude as
that for GFR mutest®, is not statistically significant, which may
be due to the much greater variability when GFR is measured
by creatinine clearance: The number of observations was the
same, but the SEM was almost three times greater. The most
significant results obtained in the subjects in whom cardiac
output was also measured are given in Figure 1. Clearly, these
two groups of subjects have similar cardiac output and BP, but
the RBF and GFR of the offspring of hypertensive parents were
higher.
Discussion
Our results demonstrate that the renal function pattern of HP
is different from that of NP. The former have greater RPF and
GFR and lower PRA than the latter. The difference in RPF was
already statistically significant in our earlier study [12] of a
smaller number of subjects, but the differences in GFR and
PRA, although seen in that study, were not significant. Essen-
tial hypertension develops through interaction of polygenic and
environmental factors. Thus, assuming that the HP, as a group,
are homogenous with regard to some functional modification
relevant to blood pressure control is unlikely to be correct.
Moreover, we know that only a proportion of these subjects will
develop hypertension later in life [21]. Thus, our speculations
might pertain to only a subgroup of subjects prone to develop
"essential" hypertension in the future.
In a recent study [11] no difference between HP and NP in
RBF was found, but the number of subjects in each group was
much smaller than in this study which may be relevant to
comparisons of a highly variable factor such as RBF. In fact,
when a larger population of early hypertensive patients was
studied, a distinct subgroup with high RBF was found [22], and
some of these patients had normal cardiac outputs [23].
The differences in response of HP and NP to stress conditions
may affect our results [11, 141. However, HP have a decrease in
RBF under stress conditions [11].
Tubular reabsorption of ions and water must be increased in
HP. This group has approximately 10% greater GFR and must
roughly have equally higher rates of tubular reabsorption to
maintain ion and water balance. The 24-hr urinary output was
Table 1. Replicate estimations of glomerular filtration rate (GFR) and
renal plasma flow (RPF) in six normal subjects
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1.75 0.02
24.3 0.7
121.1 1.5
80.4 I
69.8 1.4
7.05 0.07
45.6 0.5
20.47 1.66
172.0 8.3
47.0 1.7
1.56 0.10
2.57 + 0.13
0.34 0.03
0.32 0.02
0.47 0.04
0.51 0.05
greater in HP, while 24-hr urinary sodium excretion was the
same in the two groups. Before trying to interpret these results
we should consider that a marked day-to-day variation was seen
in the individual sodium excretion during 3 consecutive days,
probably due to day-to-day variation in sodium intake [24].
Clearly, it is difficult to determine the true mean level of salt
intake that may be involved in long-term regulation of RBF and
GFR from a single day collection. Thus, the possibility that
different levels of the mean intake of sodium may be involved in
causing the difference in RBF and GFR between HP and NP
cannot be definitely excluded. However, the greater 24-hr
urinary volume of HP, observed simultaneously to equal sodi-
um excretion, suggests a difference in the water metabolism,
per se, between the two groups. This intriguing observation
agrees with the results obtained comparing rats of the Milan
strain with genetic or spontaneous hypertension (MHS) with
the normotensive control subjects (MNS) at the prehyperten-
sive stage. In fact, MHS have a larger 24-hr intake of water and
urinary output [41 and lower plasma and urine osmolarities and
plasma vasopressin [25] while urinary sodium excretion was
equal in the two strains at this age [4]. As hypertension
develops in MHS the difference in water metabolism between
MHS and MNS disappears and renal sodium retention devel-
ops. Measurement of the osmotic gradient between the papilla
and the renal cortex showed a lower gradient in MHS because
of a lower papilla fluid osmolality (unpublished results). Wheth-
er this difference between MHS and MNS originates from a
primary kidney abnormality or from the lower plasma vasopres-
sin is open to discussion. The results of kidney transplantation
in rats [26—27] clearly show that the primary fault is within the
kidney. In humans the data on kidney transplantation are not so
conclusive. In fact, only during the first months after transplan-
tation, the recipient of the kidney removed from donors with
hypertensive families requires a significantly greater amount of
antihypertensive therapy than the recipient of the kidney taken
from normotensive families [28]. Thus, the possibility that the
renal function pattern of HP may be caused by some extrarenal
mechanisms is also open to discussion. Theoretically, an iperse-
1.72 + 0.03
22.9 0.7
113.4 1.3
75.0 1.0
66.7 1.1
7.03 0.08
44.8
24.07 2.49
164.3 5
47.5 2.3
1.64 0.14
2.65 0.21
0.28 0.02
0.30 0.02
0.46 + 0.03
0.47 0.03
Statistical
significance
of difference
P
NS
NS
<0.1
<0.01
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
NS
cretion of an unknown mineralocorticoid hormone in HP may
cause the increase of GFR and RPF. The normal values of 24 hr
urinary excretion of aldosterone in HP seems to exclude an
oversecretion of this hormone as the cause of these renal
function changes. Although they do not exclude the possibility
that a difference in sensitivity or number of the renal aldoster-
one receptors between HP and NP may be involved. If we
accept that the characteristic renal function pattern of HP is due
to primary renal dysfunction, then the next question is: What is
the primary fault that causes all these changes7 In our earlier
paper [121, we suggested that a lower glomerular ultrafiltration
coefficient might be the genetic factor responsible for the
intrarenal changes and the subsequent development of
hypertension.
We made this suggestion because of two kinds of findings: (1)
In humans some subjects with high RPF had smaller filtration
fractions and, because the difference was not statistically
significant, we under-evaluated the fact that the GFR in HP was
faster than that in NP. (2) In rats of the Milan strain with genetic
or spontaneous hypertension (MHS), a low glomerular ultrafil-
tration coefficient in the prehypertensive and early hyperten-
sive phase was the best explanation for the slower whole kidney
and single nephron filtration rates in the presence of higher
afferent hydrostatic filtration pressure (see [5, 29, 30] for a full
discussion of this hypothesis).
Stimulated by the present findings in humans, we restudied
the whole kidney GFR in young prehypertensive MHS rats and
in their controls MNS, using the Inutesta, as in the earlier
studies, but at much lower plasma concentrations (0.1 mg/mI).
Under this condition the GFR, expressed per gram of kidney
weight, is faster in young MHS than in MNS, while the
repetition of the GFR measurement with a high plasma concen-
tration, equal to that in the earlier studies (I mg/I ml), yielded
the same result as previously, that is, a slower GFR in young
MHS [31]. Clearly the earlier results were due to differential
effects of the high mutest® concentration in the two rat strains,
and it is very likely that in conscious unmanipulated rats the
GFR of the two strains are more similar to those found with low
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Table 2. Clinical characteristics, electrolytes, and hormonal profile in offspring of hypertensive and normotensive parents
Hypertensive parents
Offspring
Mean SCM
Normotensive parents
Body surface area, m2
Age, year
Blood pressure, mm Hg —Systolic
—Diastolic
Heart rate, beats/mm
Plasma protein, gidi
Hematocrit, %
Urine aldosterone, nmoles/24 hr
Urinary Na, mmoles/24 hr
Urinary K, mmoles/24 hr
Plasma noradrenaline, nmoleslliter—Su pine
Standing
Plasma adrenaline, nmoles/liter—Su pine
Standing
Plasma dopamine, nmoles/liter—Su pine
Standing
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Table 3. Renal function in offspring of hypertensive and normotensive parents
Offspring Statistical
significance
of differenceHypertensive parents Normotensive parents
Variable Mean SEM P
Glomerular filtration rate: mutest® (GFR) 138 3 127 3 <0.02
mllmin /1.73 m2 creatinine 157 8 146 8 NS
Renal plasma flow, mI/mm 1.73 m2 (RPF) 748 27 663 15 <0.01
Renal blood flow, mI/mm 1.73 m2 (RBF) 1367 58 1200 29 <0.02
Filtration fraction, (FF) 0.20 0.007 0.20 0.007 NS
Plasma renin activity, ng/ml/hrAngio I(PRA) 0.79 0.07 1.56 0.03 <0.01
24-hr Urinary output, ml/24 hr 1060 40 949 33 <0.05
0
CE') 3o
2
£ ÷ 'E 140
130
120
110
Fig. 1. Blood pressure, cardiac index, renal blood flow (RBF), and
glomerular filtration rate (GFR) in offspring of hypertensive parents
(HP: 30 subjects) and normotensive parents (NP: 34 subjects).
plasma mutest® concentration. It is important to recall here
other notable differences between young prehypertensive MHS
and MNS that are very similar to those we are describing here:
Plasma renin is lower [4], and the fraction of cardiac output
going to the kidney was greater in young MRS [321. Moreover,
in another strain of genetic hypertensive rats, the Dahl rats, in
which hypertension can be transplanted with the kidney [33],
the renal vascular resistances [34], and the plasma renin [351
also tend to be lower than in their appropriate control subjects.
Urine kallikrein is also lower in these two strains of rats [36, 37]
and in prehypertensive humans [381 than in the respective
control groups.
Thus, we have shown that in both prehypertensive MHS and
humans a pattern of changes in kidney function favoring the
lowering of BP: a larger fraction of the cardiac output going to
the kidney, a faster GFR, and lower renin. But, at least in the
rats, these kidney function changes are responsible for part of
the hypertension since it can be transplanted into normotensive
MNS with the kidney [26, 27]. How can these intriguing
observations be related to each other in a consistent sequence
of events7 This is possible in rats, at least, if we take into
consideration two additional types of information: one old and
one very recent: (1) The kidneys of prehypertensive MRS are
smaller than those of MNS [5], and (2) studies [31, 39] of red
blood cells have shown that prehypertensive MHS have smaller
red cell volume and Na content, less intracellular water, and a
faster rate of outward transport of sodium through the cell
membrane. If we postulate that the alteration in cell membrane
transport demonstrated in the red blood cell also is present in
the renal tubular cell, then the following hypothesis may be
proposed: An increase in tubular cell membrane transport is the
primary fault that drives all the other changes, that is, increased
tubular reabsorption, GFR, and the fraction of the cardiac
output that goes to the kidney, and decreased PRA. Arterial
hypertension may develop because of two independent mecha-
nisms: (1) the tendency to greater tubular reabsorption of ions
and water as previously suggested by Baldwin et al [40] and
Chasis and Baldwin [41], and (2) the long lasting, greater renal
blood flow and GFR, which may accelerate the age-related
process of sclerosis both in the small arterioles and the glomeru-
Ii [42]. This last mechanism is consistent with the relatively
earlier and selective development of renal arteriosclerotic le-
sion described in patients with essential hypertension [43, 44].
Does this hypothesis apply to humans as well? The intravas-
cular volume tends to be lower in patients with essential
hypertension and this may seem to contrast with primary
hypertensive mechanisms implying a tendency for a greater
tubular reabsorption of ions and water. However, extracellular
fluid volume, that is, the body fluid compartment more directly
related to Na and water handling by the kidney, is not de-
creased in essential hypertension [45, 47]. Both the experimen-
tal results on renal hypertension [61 and the theoretical system
analysis of Guyton, Coleman, and Granger [46] have shown
that, at the steady state, body fluids volume may well be within
the normal range even when hypertension is triggered by an
initial renal retention of sodium. Moreover, secondary structur-
al changes of the vessels may reduce their capacity, thus
decreasing the absolute amount of intravascular fluids without
affecting extracellular fluid volume. In fact, it has been shown
that in a subgroup of patients with essential hypertension the
intravascular volume may be greater than that predicted by the
level of vascular peripheral resistance [47]. The renal mecha-
nisms we are discussing in this study may trigger hypertension
only in this particular subgroup of patients. The similarities
between humans and rats mentioned here and discussed in
detail elsewhere [48] support this suggestion.
In conclusion, the difference in kidney functions in HP and
NP discussed so far strongly supports the concept that some
abnormality of kidney function, probably due to alteration of
tubular cell membrane transport, may precede the rise of blood
pressure and may be involved in the pathogenesis of "essen-
tial" hypertension.
HP
120
f' 100 fl
NP
Fi
1.5
1.3
1.1
P<0.02
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